CA1009550A - Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis) - Google Patents
Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis)Info
- Publication number
- CA1009550A CA1009550A CA185,183A CA185183A CA1009550A CA 1009550 A CA1009550 A CA 1009550A CA 185183 A CA185183 A CA 185183A CA 1009550 A CA1009550 A CA 1009550A
- Authority
- CA
- Canada
- Prior art keywords
- mucoviscidosis
- diagnosis
- cystic fibrosis
- diagnostic agent
- diagnostic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/382—Cystic fibrosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19732313744 DE2313744C3 (en) | 1973-03-20 | Procedure for the early diagnosis of cystic fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1009550A true CA1009550A (en) | 1977-05-03 |
Family
ID=5875283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA185,183A Expired CA1009550A (en) | 1973-03-20 | 1973-11-06 | Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis) |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1009550A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013008239A1 (en) * | 2011-07-14 | 2013-01-17 | Mor Gideon | Noninvasive detection of meconium in amniotic fluid |
-
1973
- 1973-11-06 CA CA185,183A patent/CA1009550A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013008239A1 (en) * | 2011-07-14 | 2013-01-17 | Mor Gideon | Noninvasive detection of meconium in amniotic fluid |
US9144520B2 (en) | 2011-07-14 | 2015-09-29 | Gideon Mor | Noninvasive detection of meconium in amniotic fluid |
Also Published As
Publication number | Publication date |
---|---|
DE2313744A1 (en) | 1974-10-03 |
DE2313744B2 (en) | 1975-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA985741A (en) | Solid state universal battery monitor | |
CA1003313A (en) | Thickened acid cleaner | |
AU463917B2 (en) | Diagnostic agent | |
AU497109B2 (en) | Agent for determining the coagulability of blood | |
CA980148A (en) | Metal impact monitor | |
CA959389A (en) | Diagnostic agent | |
CA998256A (en) | Spirometer | |
CA1016049A (en) | Aqueous cholesterol standard solution | |
CA1006091A (en) | Antiinflammatory glycyrrhetinic acid compositions | |
IL46073A0 (en) | Process for the activation of cholesterol oxidase and diagnostic agent for carrying out said process | |
AU504150B2 (en) | Echographic examination | |
CA1009550A (en) | Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis) | |
CA1028394A (en) | Anaesthesia level monitor | |
CA1010844A (en) | Process for the preparation of active carbon | |
CA1003330A (en) | Diagnostic agent | |
AU497200B2 (en) | Vehicle speed monitor | |
CA1010897A (en) | Process for the preparation of 3-acetamido-5-amino-2,4,6-triiodobenzoic acid | |
CA1011729A (en) | Derivatives of glycyrrhetinic acid | |
AU5841773A (en) | Esters of b-(3, 4-dialkanoyloxyphenyl)-alanines | |
AU475111B2 (en) | Diagnostic agents | |
CA991192A (en) | Preparation process of benzamides 2,5-disubstituted | |
CA1007303A (en) | Cardiac monitor | |
CA897387A (en) | Universal folded plate shell structures | |
CA1026344A (en) | Process for the preparation of oxadiazoline derivatives | |
CA1020358A (en) | Dry blasting agents |